EUVIMEDEUVIMED entdecken
Crossref

Gain-of-glycosylation in breast multi-drug-resistant MCF-7 adenocarcinoma cells and cancer stem cells characterized by site- and structure-specific N-glycoproteomics

Suideng Qin, Zhixin Tian

Analytica Chimica Acta · 2023

DOI: 10.1016/j.aca.2023.341029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023. Verfasst von Suideng Qin und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Science & Engineering, Shanghai Key Laboratory of Chemical Assessment and Sustainability, Tongji University, Shanghai, 200092, Chi…. Hauptthemen laut MEDLINE: COVID-19, Adenocarcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-linked glycosylation (N-glycosylation) is a common protein post-translational modification, occurring on more than half of mammalian proteins; in striking contract with small molecule modifications (such as methylation, phosphorylation) with only single structures, N-glycosylation has multiple dimensional structural features (monosaccharide composition, sequence, linkage, anomer), which generates enormous N-glycan structures; and these structures widely regulate protein structure and functions. For the modification site, N-glycosylation occurs on the Asn residue among the consensus N-X-S/T/C (X≠P) motif; mutation-originated amino acid change may lead to loss of such an original motif and thus loss-of-glycosylation (LoG) or gain of such a new motif and thus gain-of-glycosylation (GoG). Both LoG and GoG generates new structures and functions of glycoproteins, which has been observed in the S protein of SARS-Cov-2 as well as malignant diseases. Here we report our glycoproteome-wide qualitative N-glycoproteomics characterization of GoGs in breast cancer Adriamycin drug resistance (ADR) cells (MCF-7/ADR) and cancer stem cells (MCF-7/ADR CSCs); comprehensive N-glycosite and N-glycan structure information at the intact N-glycopeptide level were reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AdenocarcinomaAnimalsHumansGlycosylationMCF-7 CellsGlycopeptidesSARS-CoV-2GlycoproteinsPolysaccharidesDoxorubicinNeoplastic Stem CellsMammals

Stichwörter der Autor:innen

Gain-of-glycosylationMCF-7/ADR cancer Stem cellsMCF-7/ADR cellsMutationN-glycoproteomics

Substanzen

GlycopeptidesGlycoproteinsPolysaccharidesDoxorubicin

Autor:innen und Institutionen

  • School of Chemical Science & Engineering, Shanghai Key Laboratory of Chemical Assessment and Sustainability, Tongji University, Shanghai, 200092, China.
  • School of Chemical Science & Engineering, Shanghai Key Laboratory of Chemical Assessment and Sustainability, Tongji University, Shanghai, 200092, China. Electronic address: zhixintian@tongji.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Qin, S., & Tian, Z. (2023). Gain-of-glycosylation in breast multi-drug-resistant MCF-7 adenocarcinoma cells and cancer stem cells characterized by site- and structure-specific N-glycoproteomics. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341029

Vancouver

Qin S, Tian Z. Gain-of-glycosylation in breast multi-drug-resistant MCF-7 adenocarcinoma cells and cancer stem cells characterized by site- and structure-specific N-glycoproteomics. Analytica Chimica Acta. 2023. doi:10.1016/j.aca.2023.341029

BibTeX
@article{Qin2023,
  author = {Qin, Suideng and Tian, Zhixin},
  title = {Gain-of-glycosylation in breast multi-drug-resistant MCF-7 adenocarcinoma cells and cancer stem cells characterized by site- and structure-specific N-glycoproteomics},
  journal = {Analytica Chimica Acta},
  year = {2023},
  doi = {10.1016/j.aca.2023.341029}
}
Kostenlos starten →